{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:49:14Z","timestamp":1790455754870,"version":"4.1.0"},"reference-count":98,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"10","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO"],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:p> Pharmacogenomics (PGx), the study of inherited genomic variation and drug response or safety, is a vital tool in precision medicine. In oncology, testing to identify PGx variants offers patients the opportunity for customized treatments that can minimize adverse effects and maximize the therapeutic benefits of drugs used for cancer treatment and supportive care. Because individuals of shared ancestry share specific genetic variants, PGx factors may contribute to outcome disparities across racial and ethnic categories when genetic ancestry is not taken into account or mischaracterized in PGx research, discovery, and application. Here, we examine how the current scientific understanding of the role of PGx in differential oncology safety and outcomes may be biased toward a greater understanding and more complete clinical implementation of PGx for individuals of European descent compared with other genetic ancestry groups. We discuss the implications of this bias for PGx discovery, access to care, drug labeling, and patient and provider understanding and use of PGx approaches. Testing for somatic genetic variants is now the standard of care in treatment of many solid tumors, but the integration of PGx into oncology care is still lacking despite demonstrated actionable findings from PGx testing, reduction in avoidable toxicity and death, and return on investment from testing. As the field of oncology is poised to expand and integrate germline genetic variant testing, it is vital that PGx discovery and application are equitable for all populations. Recommendations are introduced to address barriers to facilitate effective and equitable PGx application in cancer care. <\/jats:p>","DOI":"10.1200\/jco.23.01748","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T20:59:34Z","timestamp":1708635574000},"page":"1181-1192","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":34,"title":["Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology"],"prefix":"10.1200","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7817-9296","authenticated-orcid":false,"given":"Sharon P.","family":"Shriver","sequence":"first","affiliation":[{"name":"ACS CAN, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8686-8518","authenticated-orcid":false,"given":"Devon","family":"Adams","sequence":"additional","affiliation":[{"name":"ACS CAN, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9239-7153","authenticated-orcid":false,"given":"Brittany Avin","family":"McKelvey","sequence":"additional","affiliation":[{"name":"Friends of Cancer Research, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannine S.","family":"McCune","sequence":"additional","affiliation":[{"name":"City of Hope\/Beckman Research Institute Department of Hematologic Malignancies Translational Sciences, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6351-0441","authenticated-orcid":false,"given":"Dale","family":"Miles","sequence":"additional","affiliation":[{"name":"Genentech, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2871-5051","authenticated-orcid":false,"given":"Victoria M.","family":"Pratt","sequence":"additional","affiliation":[{"name":"Agena Bioscience, San Diego, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Ashcraft","sequence":"additional","affiliation":[{"name":"Invitae Corporation, San Francisco, CA"},{"name":"YouScript, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9004-9232","authenticated-orcid":false,"given":"Howard L.","family":"McLeod","sequence":"additional","affiliation":[{"name":"Utah Tech University, St George, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2082-7211","authenticated-orcid":false,"given":"Hannah","family":"Williams","sequence":"additional","affiliation":[{"name":"Color, Burlingame, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1338-6171","authenticated-orcid":false,"given":"Mark E.","family":"Fleury","sequence":"additional","affiliation":[{"name":"ACS CAN, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"b1","doi-asserted-by":"publisher","DOI":"10.1200\/PO.21.00312"},{"key":"b2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxy079"},{"key":"b3","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12030421"},{"key":"b4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00080-7"},{"key":"b5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30321"},{"key":"b6","first-page":"1603","volume":"14","author":"White C","year":"2021","journal-title":"Pharmgenomics Pers Med"},{"key":"b7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02364"},{"key":"b8","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.101197"},{"key":"b9","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2978"},{"key":"b10","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.279"},{"key":"b11","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.911"},{"key":"b12","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2023.100782"},{"key":"b13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02780"},{"key":"b14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203033119"},{"key":"b15","volume-title":"Using Population Descriptors in Genetics and Genomics Research: A New Framework for an Evolving Field","author":"National Academies of Sciences, Engineering, and Medicine","year":"2023"},{"key":"b16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.25473"},{"key":"b17","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.172"},{"key":"b18","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01084-0"},{"key":"b19","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-021-02385-x"},{"key":"b20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.02.048"},{"key":"b22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.06.067"},{"key":"b23","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3060"},{"key":"b24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.837164"},{"key":"b25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.4671"},{"key":"b26","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-017-1608-x"},{"key":"b27","doi-asserted-by":"publisher","DOI":"10.3390\/genes13020311"},{"key":"b28","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.120.000320"},{"key":"b29","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707570"},{"key":"b30","volume-title":"Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER) (2020) Enhancing the Diversity of Clinical Trial Populations \u2014 Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry","author":"Department of Health and Human Services"},{"key":"b31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00754"},{"key":"b32","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-018-05049-5"},{"key":"b33","volume-title":"Multiple Comparisons Problem (2023, January 13)"},{"key":"b34","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1020"},{"key":"b35","doi-asserted-by":"publisher","DOI":"10.3390\/genes11121456"},{"key":"b36","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-021-00352-1"},{"key":"b37","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11020131"},{"key":"b38","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0353"},{"key":"b39","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13780"},{"key":"b40","volume-title":"Comparison of Population Characteristics in Real-World Clinical Oncology Databases in the US: Flatiron Health, SEER, and NPCR","author":"Ma X","year":"2020"},{"key":"b41","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-01056-y"},{"key":"b42","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0747"},{"key":"b43","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocz194"},{"key":"b44","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2172"},{"key":"b45","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60404-8"},{"key":"b46","doi-asserted-by":"publisher","DOI":"10.1038\/s43586-021-00056-9"},{"key":"b47","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-02053-5"},{"key":"b48","volume-title":"All of Us Research Program Overview","author":"Department of Health &amp; Human Services, National Institutes of Health","year":"2021"},{"key":"b49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272522"},{"key":"b50","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11030179"},{"key":"b51","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34104"},{"key":"b52","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01841-4"},{"key":"b53","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.698148"},{"key":"b54","volume-title":"Table of Pharmacogenetic Associations","author":"FDA","year":"2022"},{"key":"b55","volume-title":"Table of Pharmacogenomic Biomarkers in Drug Labeling","author":"FDA","year":"2023"},{"key":"b56","volume-title":"Clinical Pharmacogenomics: Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling","author":"FDA","year":"2013"},{"key":"b68","volume-title":"Project Renewal","author":"FDA","year":"2023"},{"key":"b69","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-017-2163-x"},{"key":"b70","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxac064"},{"key":"b71","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1720"},{"key":"b72","volume-title":"A Cross-Reference of PGx Drug-Gene Association Listings in FDA\u2019s Table of Pharmacogenetic Associations and CPIC Clinical Guidelines","author":"Personalized Medicine Coalition","year":"2023"},{"key":"b73","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920974118"},{"key":"b74","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21722"},{"key":"b75","volume-title":"Haute Autorit\u00e9 de Sant\u00e9","year":"2018"},{"key":"b76","volume-title":"EMA Recommendations on DPD Testing","year":"2020"},{"key":"b77","volume-title":"Medicines & Healthcare Products Regulatory Agency","year":"2020"},{"key":"b78","volume-title":"Dihydropyrimidine Dehydrogenase (DPD) Gene Mutation Analysis","author":"Quest Diagnostics"},{"key":"b79","volume-title":"DPYD Genotyping","author":"Labcorp","year":"2023"},{"key":"b80","volume-title":"Learn about the Genes Color Analyzes","author":"Color","year":"2023"},{"key":"b81","volume-title":"Dihydropyrimidine Dehydrogenase (DPYD), 3 Variants","author":"ARUP Laboratories","year":"2023"},{"key":"b82","volume-title":"The RightMed Test","author":"OneOme","year":"2023"},{"key":"b83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2018.01.011"},{"key":"b84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2019.04.003"},{"key":"b85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2020.04.204"},{"key":"b86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2021.05.013"},{"key":"b87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2022.06.007"},{"key":"b88","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09171-6"},{"key":"b89","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.859846"},{"key":"b90","volume-title":"NHE Fact Sheet","author":"Centers for Medicare &amp; Medicaid Services","year":"2021"},{"key":"b91","volume-title":"NHE MolDX: Pharmacogenomics Testing","author":"Centers for Medicare &amp; Medicaid Services","year":"2020"},{"key":"b93","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2019.10.003"},{"key":"b94","volume-title":"Pharmacogenomic Testing 2023-02-12","author":"Carelon"},{"key":"b95","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34271"},{"key":"b96","doi-asserted-by":"publisher","DOI":"10.1177\/1049732319858325"},{"key":"b97","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-021-01186-x"},{"key":"b98","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.371"},{"key":"b99","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.137"},{"key":"b100","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2013-001993"},{"key":"b101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268534"},{"key":"b102","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2022.09.002"},{"key":"b103","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.707"},{"key":"b104","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010814-124835"},{"key":"b105","doi-asserted-by":"publisher","DOI":"10.1370\/afm.2908"},{"key":"b106","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocab064"},{"key":"b107","volume-title":"The Current State of Hospital Finances: Fall 2022 Update","author":"American Hospital Association","year":"2022"},{"key":"b108","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1257745"},{"key":"b109","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2023-0096"},{"key":"b110","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2754"},{"key":"b111","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-021-00249-1"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.23.01748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T22:02:36Z","timestamp":1711576956000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.23.01748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":98,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,4,1]]}},"alternative-id":["10.1200\/JCO.23.01748"],"URL":"https:\/\/doi.org\/10.1200\/jco.23.01748","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]},"assertion":[{"value":"2023-08-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}